OncoDiscovery Award - A New Short-Term Funding Opportunity for Early-Career Medical Oncologists Around the World

Myelo 2026: Virtual Global Congress on Multiple Myeloma

Alberto Costa on a 45-Year Journey and Future Direction - European School of Oncology

Grand Rounds by OncoDaily: AI in Oncology Edition

10 Must-Read Posts in Immuno-Oncology This Week

Bishal Gyawali: Essential Primer on Navigating Clinical Trial Reports

Runcie C.W. Chidebe on GLOBOCAN 2022: Cancer Incidence and Mortality in Africa

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition

Calculators

Body Mass Index (BMI)

Cockcroft-Gault Creatinine Clearance Calculator

BSA Calculator – Body Surface Area

Carboplatin Dose Calculator (Calvert Formula)

Child-Pugh Score Calculator

ECOG Score Calculator

IBW / Adjusted Body Weight (Devine Formula)

Bone Scan Index (BSI) Tracker

Khorana Score (Cancer-Associated VTE Risk)

MASCC Risk Index Calculator (Febrile Neutropenia)

IMDC Risk Score Calculator (Metastatic RCC)

Oncotype DX Recurrence Score (RS) Categorizer

Cisplatin Cumulative Dose Toxicity Tracker

MASCC Risk Index Calculator (Febrile Neutropenia)

Identify low-risk febrile neutropenia patients using the MASCC (Multinational Association for Supportive Care in Cancer) risk index.

Check if YES (0 points), leave unchecked if NO (+5 points)

Check if YES (0 points), leave unchecked if NO (+4 points)

Check if YES (0 points), leave unchecked if NO (+3 points)

Check if YES (+3 points), leave unchecked if NO (0 points)

Check if YES (+2 points), leave unchecked if NO (0 points)

MASCC Risk Index Scoring:

  • Burden of illness: No/mild = 5, Moderate = 3, Severe = 0
  • No hypotension: +5 points
  • No COPD: +4 points
  • No dehydration: +3 points
  • Solid tumor/no fungal infection: +4 points
  • Outpatient at onset: +3 points
  • Age <60 years: +2 points

Risk Classification:

  • Low risk: ≥21 points (suitable for outpatient management)
  • High risk: <21 points (requires inpatient management)